Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ZNF529 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LST1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF567 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
USP53 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MTPAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM217B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM87A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACTR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRPEL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KANSL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MBNL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF721 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPM1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM37 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAP3K1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRMT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EWSR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on